Skip to main content

Breakthrough T1D insurance and appeals guide

Practical guidance on prior authorisation, denials, and appeals for insulin, continuous glucose monitors, pumps, and test strips.

Best for

Anyone whose insurer has denied a CGM, a pump, or a quantity of test strips.

Why Kave includes this

Denials for diabetes technology are routine and are overturned on appeal far more often than people expect — but only if someone writes the appeal. This guide tells you what to say and what evidence to attach, which is the difference between a denial that sticks and one that does not.

Limitations Kave wants you to know about

  • Guidance, not representation — nobody files the appeal for you.
  • Oriented to type 1 diabetes, though much of it applies to type 2 technology denials.
  • Plan rules differ; your own plan documents are the authority.

Verification

Compiled by Kave on July 1, 2026 and link-checked. Not yet independently verified. Kave assembled this from the organisation’s own published material and confirmed the links resolve. No reviewer has confirmed the eligibility details against the source, so check them on the official site before you rely on them.

Compiled
July 1, 2026 (28 days ago)
Next scheduled review
September 29, 2026
Reviewed by
Not yet reviewed

Sources used

Kave quality score

86/100

Kave lists resources scoring 80 or above that also clear all four mandatory gates.

  • Patient impact21/25
  • Affordability or financial value19.2/20
  • Transparency13.2/15
  • Accessibility12/15
  • Ease of use7.6/10
  • Geographic reach4.7/5
  • Institutional credibility4.5/5
  • Privacy and data practices4.2/5

Geographic reach is deliberately worth only five points, so a strong local resource is not pushed out by a weak national one. Read the methodology.

Breakthrough T1D insurance and appeals guide | Kave Health